XML 136 R121.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Parent Only Financial Information Condensed Statements of Cash Flows (Details) - USD ($)
 3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Net Cash Provided by (Used in) Operating Activities                      
Net income $ 4,064,000 $ 5,301,000 $ 3,289,000 $ 3,649,000 $ 4,037,000 $ 2,584,000 $ 1,886,000 $ 3,397,000 $ 16,303,000 $ 11,905,000 $ 14,909,000
Equity in undistributed earnings of consolidated subsidiaries                 (459,000) (354,000)  
Share-based compensation                 1,004,000 1,078,000 994,000
Excess tax benefit from share-based compensation                 (46,000) (66,000) (142,000)
Net increase (decrease) in other liabilities                 7,672,000 1,907,000 1,367,000
Other, net                 (4,428,000) (2,857,000) (3,861,000)
Net cash provided by operating activities                 25,694,000 22,408,000 26,162,000
Net Cash Provided by (Used in) Investing Activities                      
Net cash used in investing activities                 (138,266,000) (46,353,000) (44,308,000)
Net Cash Provided by (Used in) Financing Activities                      
Net (decrease) increase in short-term borrowed funds                 0 (1,000,000) (1,500,000)
Proceeds from issuance of subordinated notes payable                 0 9,090,000 0
Repayment of subordinated notes payable                 0 (7,875,000) 0
Purchase of treasury stock                 (533,000) (323,000) (467,000)
Cash dividends paid                 (4,916,000) (4,538,000) (4,176,000)
Net cash (used in) provided by financing activities                 146,579,000 (1,033,000) (17,901,000)
Net (decrease) increase in cash and cash equivalents                 34,007,000 (24,978,000) (36,047,000)
Cash and cash equivalents at the beginning of the period       52,539,000       77,517,000 52,539,000 77,517,000 113,564,000
Cash and cash equivalents at the end of the period 86,546,000       52,539,000       86,546,000 52,539,000 77,517,000
Parent company                      
Net Cash Provided by (Used in) Operating Activities                      
Net income                 16,303,000 11,905,000 14,909,000
Equity in undistributed earnings of consolidated subsidiaries                 (20,094,000) (15,086,000) (18,719,000)
Share-based compensation                 1,004,000 1,078,000 994,000
Excess tax benefit from share-based compensation                 (24,000) (37,000) (83,000)
Net increase (decrease) in other liabilities                 321,000 (4,170,000) 1,198,000
Other, net                 72,000 (2,233,000) (3,162,000)
Net cash provided by operating activities                 (2,418,000) (8,543,000) (4,863,000)
Net Cash Provided by (Used in) Investing Activities                      
Dividends received from subsidiaries                 10,034,000 14,534,000 13,534,000
Capital contributions to subsidiaries                 0 0 (3,500,000)
Net cash used in investing activities                 10,034,000 14,534,000 10,034,000
Net Cash Provided by (Used in) Financing Activities                      
Net (decrease) increase in short-term borrowed funds                 60,000 (1,000,000) (1,500,000)
Proceeds from issuance of subordinated notes payable                 0 9,090,000 0
Repayment of subordinated notes payable                 0 (7,875,000) 0
Purchase of treasury stock                 (533,000) (323,000) (467,000)
Cash dividends paid                 (4,916,000) (4,538,000) (4,176,000)
Net cash (used in) provided by financing activities                 (5,389,000) (4,646,000) (6,143,000)
Net (decrease) increase in cash and cash equivalents                 2,227,000 1,345,000 (972,000)
Cash and cash equivalents at the beginning of the period       $ 1,472,000       $ 127,000 1,472,000 127,000 1,099,000
Cash and cash equivalents at the end of the period $ 3,699,000       $ 1,472,000       $ 3,699,000 $ 1,472,000 $ 127,000